The aim of this study is to evaluate the negativation time of chlamydial and gonococcal PCRs after treatment for urogenital, oropharyngeal and anal infections.
- Patients attending the Trait d'Union department at the Nouvel Hôpital Civil for PrEP consultations, AES or HIV infection.
Over 18 years of age
Male or female
Who have had an uncomplicated CT and/or NG infection treated with currently recommended therapies (Ceftriaxone 500mg DU for NG infections, Doxycycline 200mg per day for 1 week for rectal CT infections and Azithromycin 1g DU or Doxycycline 7 days for other CT infections).
- Complicated CT and/or NG infections: epididymitis, prostatitis, upper genital infection, extra-genital involvement (keratoconjunctivitis, arthritis, skin involvement, Fiessinger-Leroy-reiter syndrome, Fitz-Hugh-Curtis syndrome).
Interfering treatments and associated diseases: Severe immunosuppression (HIV infection with CD4 less than 200/mm3, chemotherapy in the last 6 months, active haemopathy, congenital immune deficiency, immunosuppressive treatment including corticosteroid therapy for more than 4 weeks or organ transplant.
Impossibility of giving the subject informed information (subject in an emergency situation, difficulties in understanding the subject, etc.).
Subject under court protection
Single group
Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) NAAT(s)
Diagnostic testTest every week after the start of treatment, until NAAT negativation and up to a maximum of 4 weeks
Estimate the rate of negativation of NAATs performed at the various sites of CT infection
Click on the lead sponsor to view all of their trials.
